10-K · February 20, 2026
Olin presents a diversified, vertically integrated chemicals and ammunition business with Chlor Alkali (54% of 2025 sales), Epoxy (20%) and Winchester (26%) core segments. Full-year 2025 revenue was roughly $6.78…
Earnings analysis · 10-Q
Filed May 8, 2026 · Our reading of the company's report
The latest report
Olin Corporation reported a challenging first quarter in 2026, with revenues declining to $1.583 billion and an EBITDA drop to $86.2 million, heavily impacted by lower operational performance across key segments and…
Olin Corporation reported a challenging first quarter in 2026, with revenues declining to $1.583 billion and an EBITDA drop to $86.2 million, heavily impacted by lower operational performance across key segments and increased litigation costs. The company experienced a significant EPS loss of -$0.73, missing estimates again amid rising operational costs and market pressures.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Revenue decreased to $1.583 billion from $1.644 billion in Q1 2025, a decline of $61.2 million.
Diluted EPS reported at -$0.73, down from $0.01 in Q1 2025.
The Chlor Alkali segment incurred a $36.1 million charge related to legacy litigation, affecting overall profitability.
Chlor Alkali Products reported a loss of $(44.5) million, down from a profit of $78.3 million.
Epoxy segment losses narrowed to $(2.9) million from $(28.4) million due to lower costs and higher volumes.
Capital expenditures amounted to $43.7 million, down from $61.4 million in the same quarter last year.
Raw material costs increased significantly, impacting margins, particularly in Chlor Alkali Products segment.
Global epoxy demand remains weak, contributing to ongoing operational pressure.
Increased debt levels with net borrowings of $170.3 million could strain liquidity going forward.
Olin expects second quarter 2026 operating results to improve from Q1 levels, but did not provide specific numeric revenue or EPS guidance.
Olin presents a diversified, vertically integrated chemicals and ammunition business with Chlor Alkali (54% of 2025 sales), Epoxy (20%) and Winchester (26%) core segments. Full-year 2025 revenue was roughly $6.78…
Olin reported Q2 sales of $2,616.1 million, up from $2,221.3 million a year earlier, driving a larger gross profit and operating income. Diluted EPS rose to $2.76 (Q2 2021: $2.17) and operating cash flow for the six…
Olin reported strong Q1 results: sales rose to $2,461.4 million (from $1,918.8 million a year ago) and diluted EPS increased to $2.48 (from $1.51). Gross margin expanded to ~26.6% and operating margin to ~22.2%,…
Olin positions itself as the leading global chlor alkali and derivatives producer with a three-segment business mix (Chlor Alkali Products & Vinyls, Epoxy, Winchester). The company emphasizes a cost-advantaged,…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.